Lymphovascular Invasion as a Prognostic Factor in Melanoma

The prognostic significance of lymphovascular invasion (LVI) in melanoma remains controversial. Clinicopathologic data from a prospective trial of patients with melanoma were analyzed with respect to LVI. Disease-free survival and overall survival (OS) were evaluated by Kaplan-Meier (KM) analysis. Univariate and multivariate analyses were performed to evaluate factors predictive of tumor-positive sentinel nodes (SLN) and survival. A total of 2183 patients were included in this analysis; 171 (7.8%) had LVI. Median follow-up was 68 months. Factors associated with LVI included tumor thickness, ulceration, and histologic subtype (P < 0.05). LVI was associated with a greater risk of SLN metastasis (P < 0.05). By KM analysis, LVI was associated with worse OS (P = 0.0009). On multivariate analysis, age, gender, thickness, ulceration, anatomic location, and SLN status were predictors of OS; however, LVI was not an independent predictor of OS. Among patients with regression, the 5-year OS rate was 49.4 per cent for patients with LVI versus 81.1 per cent for those with no LVI (P < 0.0001). LVI is associated with a greater risk of SLN metastasis. Although LVI is not an independent predictor of OS in general, it is a powerful predictor of worse OS among patients who have evidence of regression of the primary tumor.

[1]  R. Scolyer,et al.  Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. L. Bowen,et al.  Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. , 2010, Archives of surgery.

[3]  K. Griffith,et al.  Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? , 2009, Cancer.

[4]  T. Uchida,et al.  Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma. , 2009, Journal of the American Academy of Dermatology.

[5]  J. Gershenwald,et al.  Immunohistochemical detection of lymphovascular invasion with D2‐40 in melanoma correlates with sentinel lymph node status, metastasis and survival , 2009, Journal of cutaneous pathology.

[6]  A. Chang,et al.  Prognostic Significance of a Positive Nonsentinel Lymph Node in Cutaneous Melanoma , 2009, Annals of Surgical Oncology.

[7]  Zhihai Ma,et al.  Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis , 2009, Journal of cutaneous pathology.

[8]  K. Griffith,et al.  Do Micromorphometric Features of Metastatic Deposits Within Sentinel Nodes Predict Nonsentinel Lymph Node Involvement in Melanoma? , 2008, Annals of Surgical Oncology.

[9]  L. From,et al.  Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. , 2008, Archives of dermatology.

[10]  S. Ariyan,et al.  Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. , 2007, The Journal of surgical research.

[11]  R. Elashoff,et al.  Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.

[12]  Angela M Lewis,et al.  Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Ariyan,et al.  Gender-Related Differences in Outcome for Melanoma Patients , 2006, Annals of surgery.

[14]  S. Soong,et al.  Clinical Significance of Occult Metastatic Melanoma in Sentinel Lymph Nodes and Other High-risk Factors Based on Long-term Follow-up , 2005, World Journal of Surgery.

[15]  M. Ross,et al.  Lessons learned from the Sunbelt Melanoma Trial , 2004, Journal of surgical oncology.

[16]  Jeremy MG Taylor,et al.  Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model , 2004, Annals of Surgical Oncology.

[17]  A. Stromberg,et al.  Correlation Between Prognostic Factors and Increasing Age in Melanoma , 2004, Annals of Surgical Oncology.

[18]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Ross,et al.  Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. , 2001, Surgery.

[20]  P. V. van Diest,et al.  The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma , 2001, Cancer.

[21]  P. Diest,et al.  Are Locoregional Cutaneous Metastases in Melanoma Predictable? , 1999, Annals of Surgical Oncology.

[22]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Leong,et al.  Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. , 1998, Archives of dermatology.

[24]  L. Akslen,et al.  Independent prognostic importance of vascular invasion in nodular melanomas , 1996, Cancer.

[25]  G. Halliday,et al.  Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. , 1991, The Journal of investigative dermatology.

[26]  M. Cook,et al.  Vascular Invasion in Malignant Melanomas: An Independent Prognostic Variable? , 1989, The American journal of surgical pathology.

[27]  Francesco Mazzoleni,et al.  Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. , 2008, International journal of surgery.

[28]  V. Sondak,et al.  The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma , 2007, Cancer.

[29]  W. Gillanders,et al.  Melanoma thickness and histology predict sentinel lymph node status. , 2001, American journal of surgery.

[30]  M. Ross,et al.  Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed? , 2001, Annals of Surgical Oncology.